SCHEMBL485671

SCHEMBL485671

O=C(NC1CCC1)c1ccc2ccccc2c1OCc1csc(-c2cccs2)n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.48
NPC1 O15118 8/20 0.48
RAB9A P51151 8/20 0.48
PKM P14618 1/20 0.45
LMNA P02545 3/20 0.44
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PBK Q96KB5 3/20 0.39
USP2 O75604 1/20 0.39
MAPT P10636 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HTT P42858 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL486100 0.88 RAB9A (0.44) KDM4ENPC1RAB9APKMLMNA
SCHEMBL485752 0.88 KDM4E (0.46) KDM4ENPC1RAB9APKMLMNA
Formic Acid SCHEMBL27713038 0.85 PIN1 (0.42) KDM4ENPC1RAB9APKMLMNA
SCHEMBL485467 0.82 CXCR2 (0.55) KDM4ENPC1RAB9APKMLMNA
SCHEMBL485291 0.77 CXCR2 (0.44) KDM4ENPC1RAB9APKMLMNA
Formic Acid SCHEMBL27693208 0.76 ALOX5AP (0.51) KDM4ERAB9ALMNAALDH1A1KMT2A
SCHEMBL486027 0.76 MAOB (0.50) KDM4ENPC1RAB9ALMNAALDH1A1
Formic Acid SCHEMBL27713042 0.74 SCN9A (0.43) KDM4ERAB9ALMNAALDH1A1MEN1
SCHEMBL485598 0.74 MAOB (0.53) KDM4ENPC1RAB9ALMNAALDH1A1
Formic Acid SCHEMBL27693263 0.74 MEN1 (0.57) KDM4ENPC1RAB9AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836158-B1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI AVENTIS DEUTSCHLAND (DE) 2012-02-01 EP claimed